Source: Virtual Congress 2020 – Clinical management of lung transplant recipients
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
M. Arjona (Barcelona, Spain), D. Espejo (Barcelona, Spain), E. Revilla (Barcelona, Spain), I. Los Arcos (Barcelona, Spain), D. Campany (Barcelona, Spain), B. Sáez (Barcelona, Spain), M. Barrecheguren (Barcelona, Spain), V. Monforte (Barcelona, Spain), I. Bello (Barcelona, Spain), M. López Meseguer (Barcelona, Spain), C. Bravo (Barcelona, Spain), C. Berastegui (Barcelona, Spain). New nebulized treatment options for bronchial infection in lung transplant. 1940

Member's Comments

No comment yet.

Related content which might interest you: The surgical treatment of lung bronchiectasis. Source: Virtual Congress 2020 – Thoracic surgery: lung cancer and infectious disease Year: 2020 Inhaled colistin following lung transplantation in colonised cystic fibrosis patients Source: Eur Respir J 2013; 42: 542-544 Year: 2013 Inhaled tobramycin for the prevention of airway stenosis after lung transplantation: A pilot study Source: Annual Congress 2011 - Improving outcomes after lung transplantation Year: 2011 Targeting small airways in asthma: the new challenge of inhaled corticosteroid treatment Source: Eur Respir J 2008; 31: 1145-1147 Year: 2008 The effectiveness of nebulizer therapy in the treatment of patients with bronchial asthma Source: Eur Respir J 2001; 18: Suppl. 33, 424s Year: 2001 Compliance with nebulized therapy in patients with chronic lung disease Source: Eur Respir J 2001; 18: Suppl. 33, 59s Year: 2001 Inhaled corticosteroid use and the incidence of lung cancer in COPD Source: Eur Respir J, 55 (2) 1901720; 10.1183/13993003.01720-2019 Year: 2020 Negative consequences of immunosuppressive therapy on bronchial healing following lung transplantation (LTx) Source: Annual Congress 2013 –Clinical studies in lung transplantation Year: 2013 Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment Source: Eur Respir J 2006; 27: 964-971 Year: 2006 Inhaled corticosteroids attenuate epithelial mesenchymal transition: implications for COPD and lung cancer prophylaxis Source: Eur Respir J, 54 (1) 1900778; 10.1183/13993003.00778-2019 Year: 2019 Nebulised therapy in preventive maintenance of bronchial stumpinsufficiency after pneumonectomy. Source: Virtual Congress 2020 – Thoracic surgery: malignancies Year: 2020 Surgical challenges in lung transplant candidates with CF Source: Annual Congress 2013 –Challenges in lung transplantation for cystic fibrosis Year: 2013 Role of inhaled corticosteroids on recurrent bronchial infection by potentially pathogenic bacteria in patients with COPD Source: Virtual Congress 2020 – COPD : inhaled corticosteroids, bronchodilators and eosinophils Year: 2020 Changes in the quality of life of pulmonary TB patients depending on the severity of bronchial obstruction when using standard antituberculosis therapy and inhaled bronchodilator therapy Source: Eur Respir J 2003; 22: Suppl. 45, 21s Year: 2003 Tolerance test for inhaled antibiotics in patients with chronic bronchial infection Source: International Congress 2018 – The airway microbiome across the spectrum of airway disease Year: 2018 Improved treatment response to dornase alfa in cystic fibrosis patients using controlled inhalation Source: Eur Respir J 2011; 38: 1328-1335 Year: 2011 Development of inhalation therapy for prevention and treatment of acute lung injury Source: Annual Congress 2010 - Acute respiratory failure Year: 2010 New indications for lung transplantation Source: Annual Congress 2013 –ME12 New indications for lung transplantation Year: 2013 Long-term safety of bilateral targeted lung denervation in patients with COPD in a single procedure Source: International Congress 2015 – Bronchoscopic treatment of COPD and asthma: valves, coils, thermoplastics and something more Year: 2015 Selection of emphysema patients for lung transplantation today Source: Annual Congress 2004 - Lung transplantation: new insights in advanced lung disease and new drug developments - do they impact on selection criteria? Year: 2004